Dbv Technologies Sa Stock Fundamentals
| DBV Stock | EUR 0.53 0.01 1.85% |
DBV Technologies SA fundamentals help investors to digest information that contributes to DBV Technologies' financial success or failures. It also enables traders to predict the movement of DBV Stock. The fundamental analysis module provides a way to measure DBV Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DBV Technologies stock.
DBV |
DBV Technologies SA Company Current Valuation Analysis
DBV Technologies' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current DBV Technologies Current Valuation | 51.36 M |
Most of DBV Technologies' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DBV Technologies SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, DBV Technologies SA has a Current Valuation of 51.36 M. This is 99.64% lower than that of the Biotechnology sector and 98.89% lower than that of the Health Care industry. The current valuation for all France stocks is 99.69% higher than that of the company.
DBV Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DBV Technologies's current stock value. Our valuation model uses many indicators to compare DBV Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DBV Technologies competition to find correlations between indicators driving DBV Technologies's intrinsic value. More Info.DBV Technologies SA is rated # 4 in return on equity category among its peers. It also is rated # 4 in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value DBV Technologies by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DBV Technologies' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.DBV Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DBV Technologies' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DBV Technologies could also be used in its relative valuation, which is a method of valuing DBV Technologies by comparing valuation metrics of similar companies.DBV Technologies is currently under evaluation in current valuation category among its peers.
DBV Fundamentals
| Return On Equity | -0.43 | |||
| Return On Asset | -0.22 | |||
| Operating Margin | (8.04) % | |||
| Current Valuation | 51.36 M | |||
| Shares Outstanding | 93.97 M | |||
| Shares Owned By Insiders | 6.50 % | |||
| Shares Owned By Institutions | 33.06 % | |||
| Price To Earning | 7.49 X | |||
| Price To Book | 1.24 X | |||
| Price To Sales | 28.00 X | |||
| Revenue | 5.71 M | |||
| Gross Profit | 5.71 M | |||
| EBITDA | (89.81 M) | |||
| Net Income | (97.81 M) | |||
| Cash And Equivalents | 125.48 M | |||
| Cash Per Share | 2.28 X | |||
| Total Debt | 12.8 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 3.58 X | |||
| Book Value Per Share | 2.26 X | |||
| Cash Flow From Operations | (108.24 M) | |||
| Earnings Per Share | (1.04) X | |||
| Target Price | 5.6 | |||
| Number Of Employees | 85 | |||
| Beta | 1.24 | |||
| Market Capitalization | 269.31 M | |||
| Total Asset | 146.72 M | |||
| Retained Earnings | (45 M) | |||
| Working Capital | 319 M | |||
| Current Asset | 335 M | |||
| Current Liabilities | 16 M | |||
| Z Score | 15.0 | |||
| Net Asset | 146.72 M |
About DBV Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DBV Technologies SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DBV Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DBV Technologies SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France. DBV TECHNOLOGIES operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 97 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in DBV Stock
DBV Technologies financial ratios help investors to determine whether DBV Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DBV with respect to the benefits of owning DBV Technologies security.